Merck & Co (MRK)

$77.18 0.45 (0.59%)

7:37 EDT MRK Stock Quote Delayed 30 Minutes

Volume:

Previous Close $76.73

Market Cap 207.64B

PE Ratio 133.07

EPS 0.58

Volume (Avg. Vol.) 1,006

Day's Range 76.73 - 76.73

52-Week Range 65.25 - 92.64

Dividend & Yield 1.92 (2.49%)

MRK Stock Predictions, Articles, and Merck & Co News

From InvestorPlace
From the Web

Avoid Merck Stock Until Shares Pull Back

By Mark R. Hake, CFA Jun 12, 2020

Merck is a great company with a leading coronavirus vaccine candidate. Despite all that, upside is limited for MRK stock. Stay away.

7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 9, 2020

Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.

Aggressive Investors Can Do Much Better Than Merck Stock

By Matt McCall and the InvestorPlace Research Staff, Editor, MoneyWire Jun 9, 2020

Merck stock has outperformed large-cap pharma stocks. But that's a low bar to clear, leaving investors with more attractive options elsewhere.

Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher

By Todd Shriber, InvestorPlace Contributor May 18, 2020

Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.

Dow Jones Today: More Bleak Jobs Data Didn’t Ding Stocks

By Todd Shriber, InvestorPlace Contributor May 14, 2020

In another instance of the market fighting off weak economic data, stocks rallied Thursday despite another spike in weekly jobless numbers.

Dow Jones Today: Stocks Swoon as the Fed Rejects Negative Rates

By Todd Shriber, InvestorPlace Contributor May 13, 2020

Stocks swooned Wednesday after Federal Reserve Chairman Jerome Powell said the novel coronavirus is creating lingering uncertainty for the U.S. economy while scoffing at the notion that negative interest rates could help the world's largest economy regain its footing.

Compare Brokers

Dow Jones Today: Stocks Sag Under Predictions Q2 Will Be Worst of 2020

By Todd Shriber, InvestorPlace Contributor Apr 28, 2020

The major equity averages didn't do much of anything Tuesday even as several big names reported earnings before the opening bell. Fortunately, there was some decent commentary from those companies, albeit cautious, indicating that the U.S. economy could start rebounding in the second half of the year.

Merck Earnings: Why MRK Stock Is 3% Lower Despite Q1 Beats

By William White, InvestorPlace Writer Apr 28, 2020

Merck (MRK) earnings for the pharmaceutical company's first quarter of 2020 have MRK stock falling Tuesday despite beating estimates.

3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb

By David Moadel, InvestorPlace Contributor Apr 28, 2020

Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.

This Stock Points to the Massive China Biotech Trend

By Matt McCall, Editor, MoneyWire Apr 23, 2020

There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.

3 Big Stock Charts for Wednesday: Coca-Cola, Mastercard, and Merck

By David Moadel, InvestorPlace Contributor Apr 22, 2020

Wednesday's big stock charts feature names that are preparing to meet with their significant support lines.

Dow Jones Today: Stocks Are Already Acting Like a Recession Is Here

By Todd Shriber, InvestorPlace Contributor Apr 21, 2020

Stocks stumbled again Tuesday as the ongoing decline in the oil pitch, coupled with fears a new coronavirus stimulus package will prove inadequate in bolstering the economy, served confirmation that a recession is setting in.

Compare Brokers

Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks

By Todd Shriber, InvestorPlace Contributor Mar 30, 2020

Friday was a down day, but four of the past five have been up days for the Dow and it's worth pointing out that after one of the most rapid corrections/bear markets on record, plenty of bad news is already being consumed, but plenty of uncertainty lingers, too.